12:00 AM
Apr 27, 2015
 |  BC Week In Review  |  Company News  |  Deals

Northwestern University, Panther Biotechnology deal

Panther exercised a 2014 option to license exclusive, worldwide rights to the university’s numonafide. The preclinical candidate is a small molecule derivative of...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >